navacaprant

5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart
Neumora, a richly funded brain drug developer, readies for an IPO
BioPharma Dive
Sun, 08/27/23 - 04:27 pm
Neumora Therapeutics
IPOs
depression
navacaprant